Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimicrobial Catheter Lock Solution in Maintaining Catheter Patency and Preventing CRBSI
NCT01101412Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of trimethoprim + sulfamethoxazole, edetate calcium disodium, ethanol in catheter-related bloodstream infection (CRBSI), catheter occlusion, sponsored by University of Texas MD Anderson Cancer Center. Status: withdrawn.
02
Drugs
trimethoprim + sulfamethoxazoleedetate calcium disodiumethanol
03
Conditions
catheter-related bloodstream infection (CRBSI)catheter occlusion
Beyond the preview
Go deeper on NCT01101412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01101412.